Alzheimer's disease

Alzheimer's disease (100)
Brain damage (21)
Brain disorder (23)
Brain injury (51)
Cerebral palsy (21)
Epilepsy (122)
Meningitis (38)
Neuropathy (13)
Paralysis (139)
Parkinson's disease (78)
Tinnitus (15)

Synopsis: Health: Illness: Nervous system diseases: Alzheimer's disease:

Tests carried out on 18 pilots at Stanford university found those given the Alzheimer's disease drug Aricept for 30 days were better able to retain complex aviation tasks learnt on a simulator than those given placebos.

People with irritable bowel syndrome, obesity, Alzheimer's disease, Parkinson's and depression have been shown to have differences in gut bacteria

#Expanding insight into Alzheimer's disease Chronic neurodegenerative diseases, such as Alzheimer's, Parkinson's and Huntington's, are all characterised by an inflammatory reaction within the brain.

The DECIDE consortium has implemented onto neugrid a popular tool for the detection of a diagnostic marker for Alzheimer's disease based on PET imaging (gridspm.

The community of imaging scientists working on Alzheimer's disease need new powerful environments to perform experiments on such datasets.

The neugrid e-infrastructure is so far the first and only European effort aiming to offer a distributed working environment to computational neuroscientists. neugrid has been developed for the front runner community of neuroscientists working in the field of Alzheimer's disease and other neurodegenerative diseases (i e.

which can lead to conditions such as Alzheimer s disease and diabetes. To investigate why this decline occurs,

Malinow, who holds the Shiley Endowed Chair in Alzheimer s disease Research in Honor of Dr. Leon Thal,

noted that the beta amyloid peptide that accumulates in the brains of people with Alzheimer s disease weakens synaptic connections in much the same way that low-frequency stimulation erased memories in the rats.

#Tau Associated MAPT Gene Increases Risk for Alzheimer's disease A international team of scientists, led by researchers at the University of California,

and Extra Copies of Disease Gene in Alzheimer s Brain cells The surprise discovery offers a new understanding of Alzheimer s disease.

and Alzheimer s disease#said Jerold Chun professor at TSRI and its Dorris Neuroscience Center and senior author of the new study.

Alzheimer s disease is an irreversible brain disease that tends to strike older people. It is progressive#impairing memory destroying motor skills and eventually causing death.

The U s. Centers for Disease Control and Prevention estimates 5. 3 million Americans currently have Alzheimer s disease

Remarkably the researchers found that more than 90 percent of sporadic Alzheimer s disease brains displayed highly significant DNA increases of hundreds of millions more DNA base-pairs compared with control samples showing that genomic mosaicism was altered in the Alzheimer s brain.

The tests showed that neurons from patients with sporadic Alzheimer s disease were four times as likely to contain more than the normal two copies of APP with some Alzheimer s neurons containing up to 12 copies of APP a phenomenon never seen in the controls.#

because the genomic signatures of sporadic Alzheimer s disease occur within individual brain cells. Indeed a majority of major brain diseases are also sporadic.

and disease the causes of mosaicism and potential new disease drug targets present in the millions of extra base-pairs found in single Alzheimer s disease neurons.

In addition to Chun Kaeser and Bushman other authors of the study#Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer s disease brains#were Jurgen

Full open access research for#Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer s disease brains#by Diane M Bushman

In this study we report altered genomic mosaicism in single sporadic Alzheimer s disease (AD) neurons characterized by increases in DNA content and amyloid precursor protein (APP) gene copy number.

or DNA sequence from one animal into the genome of another plays a critical role in a wide range of medical researchncluding cancer, Alzheimer's disease, and diabetes.

The researchers demonstrated that patients diagnosed with Alzheimer's disease had altered an'healthy ageing'RNA signature in their blood,

In particular, they demonstrated that patients diagnosed with Alzheimer's disease had altered an'healthy ageing'RNA signature in their blood,

whether the findings could have implications for Alzheimer's disease or other dementias.''We'd need to see how this gene could influence memory

Although Lewy Body disease (LBD) is the second-most-common degenerative disease after Alzheimer's disease, it's not exactly a household name.

The LBCRS was able to discriminate between Alzheimer's disease and LBD with 96.8 percent accuracy, and provided sensitivity of 90 percent and specificity of 87 percent.

#New field of application for versatile helper In Alzheimer's disease proteins clump together to long fibrils causing the death of nerve cells.

#Study finds how Alzheimer's-associated protein tangles spread through the brain Massachusetts General Hospital (MGH) investigators have discovered a mechanism behind the spread of neurofibrillary tangles-one of the two hallmarks of Alzheimer's disease-through the brains

while extremely rare even in the brains of patients with Alzheimer's disease, is able to spread from one neuron to another

"It has been postulated that tangles-the abnormal accumulation of tau protein that fills neurons in Alzheimer's disease-can travel from neuron to neuron as the disease progresses,

"says Bradley Hyman, MD, Phd, director of the MGH Alzheimer's disease Research center and senior author of the report."

#Drug Treats Protein That May Cause Alzheimer's disease The drug salsalate has been found to prevent and even reverse the development of tau protein tangles in mice with a condition similar to Alzheimer's disease.

While so far the success is only in animals, salsalate has a head start on other potential treatments as it has passed already the safety trials required to be used to treat arthritis.

As society ages, Alzheimer's disease the most common cause for dementia looms ever larger as a prime source of suffering.

#Scientists discover new gene that increases Alzheimer's disease risk An immune system gene that associated with a higher risk of Alzheimer disease has been identified by researchers in the US.

and fighting an important cause of progression in Alzheimer's disease,"said one of the team, Andrew Saykin from the Indiana University School of medicine.

Previous research has linked another genetic factor to the development of Alzheimer's disease-the APOE e4 allele.

the presence of the IL1RAP variant was associated with an overall greater likelihood of progression from mild cognitive impairment to Alzheimer's disease.

and fighting an important cause of progression in Alzheimer's disease,"said Saykin n

#China now spends more on science than the EU, will soon overtake the US On Monday,

#Genetics overlap found between Alzheimer's disease, cardiovascular risk factors The findings are published in current online issue of Circulation."

and high levels of inflammation are associated with increased risks for Alzheimer's disease, "said study co-author Paul M Ridker, MD, MPH, the Eugene Braunwald Professor of Medicine at Harvard Medical school and director of the Center for Cardiovascular disease Prevention at Brigham and Women's Hospital."

and therapeutically target individuals at increased risk for developing cardiovascular disease who are also at risk for developing Alzheimer's disease,

including Alzheimer's disease and brain injury. Previous studies found that after brain injury astrocytes produce greater amounts of p75 neurotrophin receptor (p75ntr), a protein that helps cells detect growth factors.

there is a new kid on the block Alzheimer's disease is associated with the appearance of characteristic neurotoxic protein aggregates in various regions in the brain.

which extends this picture of the pathogenesis of Alzheimer's disease, and has potentially far-reaching implications for our understanding of the condition:"

since that similar misfolded proteins may contribute to more common forms of neurodegeneration, such as Parkinson's disease and Alzheimer's disease."

the Massachusetts Alzheimer's disease Research center in Boston, the Parkinson's UK Brain Bank at Imperial College London,

Researchers discover a gene variant that provides a delaying mechanism for Alzheimer's disease Medical research has yet to discover an Alzheimer's treatment that effectively slows the disease's progression,

the work showcases the new technology and its practical importance in clinical science by showing how it has given new insights into Alzheimer's disease plaques."

and collected data that may resolve several current issues regarding the pathology of Alzheimer's disease. While Superman's x-ray vision is only the stuff of comics, our method,

model of Alzheimer's disease developed at the RIKEN BSI by Takaomi Saido team. After showing how Scales treatment can preserve tissue

the researchers put the technique to practical use by visualizing in 3d the mysterious"diffuse"plaques seen in the postmortem brains of Alzheimer's disease patients that are typically undetectable using 2d imaging.

not only for visualizing plaques in Alzheimer's disease, but also for examining normal neural circuits and pinpointing structural changes that characterize other brain diseases

A role for the protein HSD10 had been suspected in patients with Alzheimer's disease and Parkinson's disease, but no direct connection had previously been established.

when bound to the amyloid beta peptide so prevalent in Alzheimer's disease.""Normally, apoptosis is beneficial for regulating multicellular systems,

and provides a fresh perspective on the etiology of Alzheimer's disease that could inform novel drug strategies,

if this connection holds true in conditions like Parkinson's disease and Alzheimer's disease.""Applying their new assay in healthy neurons,

and may lead to new treatments that involve BNIP-H."Our findings could provide new direction to better understand causes of cholinergic-related diseases, such as Alzheimer's disease, Down's syndrome, ataxia and schizophrenia.

and may lead to new treatments that involve BNIP-H."Our findings could provide new direction to better understand causes of cholinergic-related diseases, such as Alzheimer's disease, Down's syndrome, ataxia and schizophrenia.

Ultimately, it could be used in the early diagnosis of brain tumours or Alzheimer's disease. This work is published in PNAS.

"Alzheimer's disease, epilepsy, multiple sclerosis and hydrocephalus involve changes in the stiffness of the brain tissues. This new technique allows their detection,

"This method can be used to explore the aspect of cells that changes during Alzheimer's disease, the metastasis of cancer,

These mutations cause more than 200 diseases and contribute to others such as diabetes cancer Parkinson's disease and Alzheimer's disease.

and heritable variants that have been linked to breast cancer and Alzheimer's disease, suggesting that the algorithm, combined with the researchers'sophisticated computer models of cellular regulation, is a powerful method for identifying genetic drivers of a wide range of diseases."

In a study of Alzheimer's disease, DIGGIT found 14 genetic variants that appear to drive the condition,

""Even in our studies of breast cancer and Alzheimer's disease, where the goal was simply to show that DIGGIT could identify mutations

Disruptions of the neuron train system also contribute to neurodegenerative diseases, like Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS.

scientists at the National Brain Research Centre (NBRC) have reported clinical evidence supporting the role of a novel biomarker in diagnosing Alzheimer's disease.

"Several animal studies conducted at NBRC have showed the utility of this biomarker in diagnosing Alzheimer's disease previously also.

a region of the brain, yielded 100%specificity and sensitivity for distinguishing Alzheimer's disease and healthy controls."

"We propose that estimation of GSH affords a crucial noninvasive measure of Alzheimer's disease progression that could

and treatment of neurological diseases ranging from autism to Alzheimer's disease to multiple sclerosis.""Instead of asking,'How do we study the immune response of the brain?''

take Alzheimer's disease.""In Alzheimer's, there are accumulations of big protein chunks in the brain, "Kipnis said."

#Enriched Blood cells Preserve Cognition In Mice With Features Of Alzheimer's disease, Cedars-Sinai Medical center Study Enriched Blood cells Preserve Cognition In Mice With Features Of Alzheimer's disease Los angeles-July 6,

2015 Cedars-Sinai researchers have tested successfully two new methods for preserving cognition in laboratory mice that exhibit features of Alzheimer's disease by using white blood cells from bone marrow

and a drug for multiple sclerosis to control immune response in the brain. Under the two approaches, immune cells from outside the brain were found to travel in greater numbers through the blood into the brain.

During the progression of Alzheimer's disease, these cells are found to be defective. In this study, the researchers discovered that immune cells infiltrating the brain from the blood effectively resisted various abnormalities associated with the condition."

"These cells appear to work in the brain in several ways to counter the negative effects associated with Alzheimer's disease,

"The increasing incidence of Alzheimer's disease and the lack of any effective therapy make it imperative to explore new strategies, especially those that can target multiple abnormalities in such a complicated disease,"Koronyo-Hamaoui added.

In Alzheimer's disease, a protein fragment known as amyloid-beta builds up at the synapses of neurons the point where neuron-to-neuron communication occurs.

'The scientists hope that understanding how this type of memory is formed could someday help patients suffering from certain neurological disorders, such as Alzheimer's disease e

this knowledge can be helpful in the development of therapeutic interventions for neurological diseases underlined by altered dendritic spine density, such as autism spectrum disorder, Schizophrenia or Alzheimer's disease.

#Leaky Blood vessels In The Brain May Lead To Alzheimer's Researchers appear to have found a new risk factor for Alzheimer's disease:

The new research grew out of earlier studies of people who died with Alzheimer's disease.""We were looking at brains from autopsies

"There's every reason to think that a lot of Alzheimer's disease does involve vascular damage, "he says. The study also adds to the evidence that amyloid plaques

#Alzheimer's plaques reduced by targeting sugar attachment to the BACE1 enzyme A major factor contributing to Alzheimer's disease is the formation of pathogenic A?

and Naoyuki Taniguchi at RIKEN in collaboration with Tamao Endo and Shigeo Murayama at the Tokyo Metropolitan Institute of Gerontology showed that much of the BACE1 found in the brains of Alzheimer's disease patients is modified by the attachment of a particular sugar with the help of the enzyme

and neurodegenerative disorders, including depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's disease, AIDS dementia complex, asphyxia in newborns and epilepsy.

and to understanding the basis of neurodevelopmental and neurodegenerative disorders such as schizophrenia Alzheimer's disease and epilepsy.

The discovery could lead to targeted therapies and interventions for Alzheimer's disease, autism and other neurological conditions.

take Alzheimer's disease.""In Alzheimer's, there are accumulations of big protein chunks in the brain, "Kipnis said."

has identified a gene that underlies healthy information processing--a first step on a complicated road to understand cognitive aging and age-related diseases, such as Alzheimer's disease.

#Discovery about brain protein causes rethink on development of Alzheimer's disease Researchers at the University of Melbourne have discovered that a protein involved in the progression of Alzheimer's disease also has properties that could be helpful for human health.

The discovery helps researchers better understand the complicated brain chemistry behind the development of Alzheimer's disease, a condition that affects hundreds of thousands of Australians.

Researchers have been interested intensely in the role of beta-amyloid in the development of Alzheimer's disease. This is because clumps of the protein are formed in brains of people with the illness.

and the number of people affected by the Alzheimer's disease continues to grow. Dr Drew and the team from Poland are now working to develop a method for identifying the copper-bound form of the short beta amyloid in the body.

"As the amount of beta amyloid in the brain increases during Alzheimer's disease, the shorter form can also clump together

This unexpected insight could lead to new treatments for Alzheimer's disease, gout and a host of other ailments,

< Back - Next >

Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011